Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Page 1
Transvaginal treatment of anterior and apical genital prolapse using Restorelle® direct fix™: An observational study of medium-term complications and outcomes.
Gauthier A, Ferry P, Bertherat P, De Tayrac R, Fernandez H. Gauthier A, et al. J Gynecol Obstet Hum Reprod. 2020 Feb;49(2):101674. doi: 10.1016/j.jogoh.2019.101674. Epub 2019 Dec 15. J Gynecol Obstet Hum Reprod. 2020. PMID: 31852622
CONCLUSION: The Restorelle mesh has good safety and efficiency in the medium term. Long-term data and comparative studies are needed....
CONCLUSION: The Restorelle mesh has good safety and efficiency in the medium term. Long-term data and comparative studies are …
Simultaneous monitoring of pazopanib and its metabolites by UPLC-MS/MS.
Paludetto MN, Puisset F, Le Louedec F, Allal B, Lafont T, Chatelut E, Arellano C. Paludetto MN, et al. J Pharm Biomed Anal. 2018 May 30;154:373-383. doi: 10.1016/j.jpba.2018.03.013. Epub 2018 Mar 9. J Pharm Biomed Anal. 2018. PMID: 29571135
No matrix effect was evidenced as demonstrated by the normalised matrix factor values: 1.3 0.1 and 1.2 0.2 respectively measured at low and high part of calibration range. A good stability of pazopanib was observed during short term, long term and in process storage …
No matrix effect was evidenced as demonstrated by the normalised matrix factor values: 1.3 0.1 and 1.2 0.2 respectively measured at low and …
Local Arctic air pollution: Sources and impacts.
Law KS, Roiger A, Thomas JL, Marelle L, Raut JC, Dalsøren S, Fuglestvedt J, Tuccella P, Weinzierl B, Schlager H. Law KS, et al. Ambio. 2017 Dec;46(Suppl 3):453-463. doi: 10.1007/s13280-017-0962-2. Ambio. 2017. PMID: 29076019 Free PMC article.
Present-day shipping/petroleum extraction emissions already appear to be impacting pollutant (ozone, aerosols) levels along the Norwegian coast and are estimated to cool and warm the Arctic climate, respectively. Future increases in shipping may lead to short-term (long …
Present-day shipping/petroleum extraction emissions already appear to be impacting pollutant (ozone, aerosols) levels along the Norwegian co …
Transvaginal repair of stage III-IV cystocele using a lightweight mesh: safety and 36-month outcome.
de Tayrac R, Brouziyne M, Priou G, Devoldère G, Marie G, Renaudie J. de Tayrac R, et al. Int Urogynecol J. 2015 Aug;26(8):1147-54. doi: 10.1007/s00192-015-2659-z. Epub 2015 Mar 3. Int Urogynecol J. 2015. PMID: 25731722
CONCLUSION: Transvaginal cystocele repair using a lightweight transobturator polypropylene mesh was safe and efficient in the medium term. Long-term data and comparative studies are needed....
CONCLUSION: Transvaginal cystocele repair using a lightweight transobturator polypropylene mesh was safe and efficient in the medium term …
[Intravitreal injections of ranibizumab in treatment of large peripapillary choroidal neovascularization].
Nochez Y, Le Lez ML, Pisella PJ. Nochez Y, et al. J Fr Ophtalmol. 2009 Jan;32(1):25-31. doi: 10.1016/j.jfo.2008.10.002. Epub 2009 Feb 4. J Fr Ophtalmol. 2009. PMID: 19515310 Clinical Trial. French.
CONCLUSION: Intravitreal ranibizumab injections appeared to be a good therapeutic option for patients with peripapillary CNV in the short term. Long-term follow-up of these patients will aid in assessing the sustained effect of the drug....
CONCLUSION: Intravitreal ranibizumab injections appeared to be a good therapeutic option for patients with peripapillary CNV in the short …
S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies.
Morain P, Lestage P, De Nanteuil G, Jochemsen R, Robin JL, Guez D, Boyer PA. Morain P, et al. CNS Drug Rev. 2002 Spring;8(1):31-52. doi: 10.1111/j.1527-3458.2002.tb00214.x. CNS Drug Rev. 2002. PMID: 12070525 Free PMC article. Review.
By retarding the degradation of neuroactive peptides, S 17092 was successfully used in a variety of memory tasks. These tasks explored short-term, long-term, reference and working memory in aged mice, as well as in rodents and monkeys with chemically induced amnesia …
By retarding the degradation of neuroactive peptides, S 17092 was successfully used in a variety of memory tasks. These tasks explored short …